Cell Therapies under Clinical Trials and Polarized Cell Therapies in Pre-Clinical Studies to Treat Ischemic Stroke and Neurological Diseases: A Literature Review

Stroke remains a major cause of serious disability because the brain has a limited capacity to regenerate. In the last two decades, therapies for stroke have dramatically changed. However, half of the patients cannot achieve functional independence after treatment. Presently, cell-based therapies ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatakeyama, Masahiro, Ninomiya, Itaru, Otsu, Yutaka, Omae, Kaoru, Kimura, Yasuko, Onodera, Osamu, Fukushima, Masanori, Shimohata, Takayoshi, Kanazawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503631/
https://www.ncbi.nlm.nih.gov/pubmed/32867222
http://dx.doi.org/10.3390/ijms21176194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503631/
https://www.ncbi.nlm.nih.gov/pubmed/32867222
http://dx.doi.org/10.3390/ijms21176194

Ejemplares similares